Pricing Log in Create free account

DiaMedica Therapeutics, Inc. (DMAC) vs MapLight Therapeutics, Inc. (MPLT)

DiaMedica Therapeutics, Inc. and MapLight Therapeutics, Inc. are both Biotechnology companies. DiaMedica Therapeutics, Inc. and MapLight Therapeutics, Inc. are of similar size ($445.7M and $433.6M). Across the 9 metrics below, DiaMedica Therapeutics, Inc. leads on 6 and MapLight Therapeutics, Inc. on 3.

Valuation

Metric DMAC MPLT Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 10.68 1.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (9.47%) (549.48%) (33.15%)
Free cash flow yield (7.70%) (50.06%) (25.50%)

Profitability

Metric DMAC MPLT Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (114.62%) (297.18%) (56.36%)
Return on assets (98.18%) (124.79%) (48.04%)
Return on invested capital 0.00% (348.44%) 0.00%

Growth

Metric DMAC MPLT Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (16.67%) 82.39% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DMAC MPLT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.72 16.52 4.72
Net debt to EBITDA 1.70 1.79 0.96

Dividend

Metric DMAC MPLT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DMAC MPLT Biotechnology median
Market cap 433.56m 445.72m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack